Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study

Guri Holmen Gundersen, Tone M Norekval, Hilde Haugberg Haug, Kyrre Skjetne, Jens Olaf Kleinau, Torbjorn Graven, Havard Dalen, Guri Holmen Gundersen, Tone M Norekval, Hilde Haugberg Haug, Kyrre Skjetne, Jens Olaf Kleinau, Torbjorn Graven, Havard Dalen

Abstract

Objectives: Medical history, physical examination and laboratory testing are not optimal for the assessment of volume status in heart failure (HF) patients. We aimed to study the clinical influence of focused ultrasound of the pleural cavities and inferior vena cava (IVC) performed by specialised nurses to assess volume status in HF patients at an outpatient clinic.

Methods: HF outpatients were prospectively included and underwent laboratory testing, history recording and clinical examination by two nurses with and without an ultrasound examination of the pleural cavities and IVC using a pocket-size imaging device, in random order. Each nurse worked in a team with a cardiologist. The influence of the different diagnostic tests on diuretic dosing was assessed descriptively and in linear regression analyses.

Results: Sixty-two patients were included and 119 examinations were performed. Mean±SD age was 74±12 years, EF was 34±14%, and N-terminal pro-brain natriuretic peptide (NT-proBNP) value was 3761±3072 ng/L. Dosing of diuretics differed between the teams in 31 out of 119 consultations. Weight change and volume status assessed clinically with and without ultrasound predicted dose adjustment of diuretics at follow-up (p<0.05). Change of oedema, NT-proBNP, creatinine, and symptoms did not (p≥0.10). In adjusted analyses, only volume status based on ultrasound predicted dose adjustments of diuretics at first visit and follow-up (all ultrasound p≤0.01, all other p≥0.2).

Conclusions: Ultrasound examinations of the pleural cavities and IVC by nurses may improve diagnostics and patient care in HF patients at an outpatient clinic, but more studies are needed to determine whether these examinations have an impact on clinical outcomes.

Trial registration number: NCT01794715.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Flow chart of the study. All participants underwent full cross-over with examinations with and without ultrasound (US) in a random order at every study visit. The sequence was randomised by draw both at first and follow-up study visits. Echocardiography for validation was only performed at first visit (N=62). Both the teams with and without access to US made therapeutic decisions based on all available information (usual care±US examination). N, number of visits; NYHA, New York Heart Association; US(−), without access to ultrasound; US(+), with access to ultrasound.
Figure 2
Figure 2
Correlation of ultrasound indices to assess volume status by nurses with reference. The figure shows correlation of: (A) quantification of pleural effusion measured as the dimension of fluid between the diaphragm and the lung surface with patients in sitting position; and (B) end-expiratory dimension of the inferior vena cava (IVC) by pocket-size imaging device (PSID) examinations performed by nurses plotted against similar measurements by reference echocardiography. In (A) no effusion measured by both the nurse and reference is shown as the dot at 0; 0 and the dot at 0.5; 0.5 refers to effusion in the costodiaphragmatic recess only measured by both users.

References

    1. Pang PS. Pathophysiology of volume overload in acute heart failure syndromes. Congest Heart Fail 2010;16:51–6.
    1. Albert NM. Fluid management strategies in heart failure. Critic Care Nurse 2012;32:20–32. 10.4037/ccn2012877
    1. von Lueder TG, Krum H. Current modalities for invasive and non-invasive monitoring of volume status in heart failure. Heart 2012;98:967–73. 10.1136/heartjnl-2011-301330
    1. Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation 2012;126:501–6. 10.1161/CIRCULATIONAHA.112.125435
    1. Faris RF, Flather M, Purcell H, et al. . Diuretic treatment, chronic heart failure. Cochrane Library 2012.
    1. McMurray JJ, Adamopoulos S, Anker SD, et al. . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 2012;33:1787–847. 10.1093/eurheartj/ehs104
    1. Fonseca C, Morais H, Mota T, et al. . The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail 2004;6:795–800. 10.1016/j.ejheart.2004.08.002
    1. Mueller C, Frana B, Rodriguez D, et al. . Emergency diagnosis of congestive heart failure: impact of signs and symptoms. Can J Cardiol 2005;21:921–4.
    1. Rohde LE, Beck-da-Silva L, Goldraich L, et al. . Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol 2004;20:697–702.
    1. Kataoka H. Utility of thoracic sonography for follow-up examination of chronic heart failure patients with previous decompensation. Clin Cardiol 2007;30:336–41. 10.1002/clc.20100
    1. Blehar DJ, Dickman E, Gaspari R. Identification of congestive heart failure via respiratory variation of inferior vena cava diameter. Am J Emerg Med 2009;27:71–5. 10.1016/j.ajem.2008.01.002
    1. Brennan JM, Blair JE, Goonewardena S, et al. . Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr 2007;20:857–61. 10.1016/j.echo.2007.01.005
    1. Pellicori P, Carubelli V, Zhang J, et al. . IVC diameter in patients with chronic heart failure: relationships and prognostic significance. JACC Cardiovasc Imaging 2013;6:16–28. 10.1016/j.jcmg.2012.08.012
    1. Kataoka H. Ultrasound pleural effusion sign as a useful marker for identifying heart failure worsening in established heart failure patients during follow-up. Congest Heart Fail 2012;18:272–7. 10.1111/j.1751-7133.2012.00285.x
    1. Andersen GN, Viset A, Mjolstad OC, et al. . Feasibility and accuracy of point-of-care pocket-size ultrasonography performed by medical students. BMC Med Educ 2014;14:156 10.1186/1472-6920-14-156
    1. Dalen H, Gundersen GH, Skjetne K, et al. . Feasibility and reliability of pocket-size ultrasound examinations of the pleural cavities and vena cava inferior performed by nurses in an outpatient heart failure clinic. Eur J Cardiovasc Nurs 2015;14:286–93. 10.1177/1474515114547651
    1. Mjolstad OC, Andersen GN, Dalen H, et al. . Feasibility and reliability of point-of-care pocket-size echocardiography performed by medical residents. Eur Heart J Cardiovasc Imaging 2013;14:1195–202. 10.1093/ehjci/jet062
    1. Sauer J, Rabelo ER, Castro RA, et al. . Nurses’ performance in classifying heart failure patients based on physical exam: comparison with cardiologist's physical exam and levels of N-terminal pro-B-type natriuretic peptide. J Clin Nurs 2010;19:3381–9. 10.1111/j.1365-2702.2010.03403.x
    1. Rudski LG, Lai WW, Afilalo J, et al. . Guidelines for the echocardiographic assessment of the right heart in adults. J Am Soc Echocardiogr 2010;23:685–713. 10.1016/j.echo.2010.05.010
    1. Goonewardena SN, Gemignani A, Ronan A, et al. . Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. JACC Cardiovasc Imaging 2008;1:595–601. 10.1016/j.jcmg.2008.06.005
    1. Brodovicz KG, McNaughton K, Uemura N, et al. . Reliability and feasibility of methods to quantitatively assess peripheral edema. Clin Med Res 2009;7:21–31. 10.3121/cmr.2009.819
    1. Raphael C, Briscoe C, Davies J, et al. . Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 2007;93:476–82. 10.1136/hrt.2006.089656
    1. Panoulas VF, Daigeler AL, Malaweera AS, et al. . Pocket-size hand-held cardiac ultrasound as an adjunct to clinical examination in the hands of medical students and junior doctors. Eur Heart J Cardiovasc Imaging 2013;14:323–30. 10.1093/ehjci/jes140
    1. Neskovic AN, Edvardsen T, Galderisi M, et al. . Focus cardiac ultrasound: the European Association of Cardiovascular Imaging viewpoint. Eur Heart J Cardiovasc Imaging 2014;15:956–60. 10.1093/ehjci/jeu081
    1. Sicari R, Galderisi M, Voigt JU, et al. . The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography. Eur J Echocardiogr 2011;12:85–7. 10.1093/ejechocard/jeq184
    1. Platz E, Solomon SD. Point-of-care echocardiography in the accountable care organization era. Circulation Cardiovasc Imaging 2012;5:676–82. 10.1161/CIRCIMAGING.112.973578
    1. Carbone F, Bovio M, Rosa GM, et al. . Inferior vena cava parameters predict re-admission in ischemic heart failure. Eur J Clin Invest 2014;44:341–9. 10.1111/eci.12238
    1. Abraham WT, Adamson PB, Bourge RC, et al. . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011;377:658–66. 10.1016/S0140-6736(11)60101-3
    1. Lainchbury JG, Troughton RW, Strangman KM, et al. . N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol 2009;55:53–60. 10.1016/j.jacc.2009.02.095
    1. Felker GM, Hasselblad V, Hernandez AF, et al. . Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422–30. 10.1016/j.ahj.2009.06.018

Source: PubMed

3
구독하다